ERBB2 and neoplasm: Patients with primary tumours with HER2 overexpression (P = 0.0046) and p53 protein accumulation (P = 0.013) had significantly reduced post-relapse survival, whereas those with positive expression of PR had significantly increased post-relapse survival (P = 0.045) (Table 4).